NEW YORK (GenomeWeb) – Startup mFluiDx — a portmanteau of "microfluidics" and "diagnostics" — is developing an inexpensive, sample-to-answer, self-digitizing quantitative microfluidic diagnostics platform that does not require an external instrument to run.

The mFludiX diagnostic is able to process whole blood with on-chip sample prep and requires simple external heating and a simple optical reader, similar to a DNA gel reader, to obtain quantitative results, mFluiDx co-founder Charlie Yeh said in an interview.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.